http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2009142806-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-146 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-145 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-141 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0065 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5161 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5138 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B82Y5-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-6951 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51 |
| filingDate | 2008-04-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-05-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2009142806-A |
| titleOfInvention | NANOPARTICLES INCLUDING CYCLODEXTRINS AND A BIOLOGICALLY ACTIVE MOLECULE, AND THEIR APPLICATION |
| abstract | 1. Nanoparticles comprising a biodegradable polymer, cyclodextrin or its derivative and biologically active molecule. ! 2. The nanoparticles according to claim 1, where the specified biodegradable polymer is a copolymer of methyl vinyl ether and maleic anhydride (PVM / MA). ! 3. The nanoparticles according to claim 1, where the specified cyclodextrin or its derivative is selected from the group consisting of β-cyclodextrin, 2-hydroxypropyl-β-cyclodextrin, 6-monodeoxy-6-monoamine-β-cyclodextrin and mixtures thereof. ! 4. Nanoparticles according to claim 1, comprising two or more biologically active molecules. ! 5. The nanoparticles according to claim 1, where the specified biologically active molecule is a small chemical molecule, protein, peptide, nucleoside, nucleotide, oligonucleotide, polynucleotide or nucleic acid. ! 6. The nanoparticles according to claim 1, where the specified biologically active molecule is a drug, antigen or allergen. ! 7. The nanoparticles according to claim 1, where the specified biologically active molecule is a hydrophobic substance or a substrate substance of the enzyme P-glycoprotein. ! 8. The nanoparticles according to claim 1, where the specified biologically active molecule is selected from the group consisting of actinomycin D, albendazole, amitriptyline, amprenavir, atorvastatin, bunitrolol, camptothecin, carvedilol, celiprolol, cyclosporine, clotrimazole, colchicine, cortisone, debrisouin, dauborizin, da dexamethasone, digitoxin, digoxin, diltiazem, docetaxel, domperidone, doxorubicin, epirubicin, erythromycin, estradiol, etoposide, phenytoin, fexofenadine, FK506, fluorouracil, gentamicin, griseofinvin, imine, imine, rakonazola, levofloxacin, losartan, |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2546535-C1 |
| priorityDate | 2007-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 131.